Intelligent Investor

Bradken Limited (ASX: BKN) - Announcements

DELISTED - Current share price for BKN : $3.240

ASX company news and announcements for Bradken Limited (BKN) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Bradken Limited (BKN) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Bradken Limited (BKN), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Bradken Limited (BKN)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
- Ceasing to be a substantial holder 15 Mar 2017 3:24PM $3.240 $3.240 $3.240 fallen by 0%
- HCM Offer - Change of substantial holding notice 15 Mar 2017 9:03AM $3.240 $3.240 $3.240 fallen by 0%
- HCM Offer - Second Supplementary Target's Statement 13 Mar 2017 5:48PM $3.240 $3.240 $3.240 fallen by 0%
- HCM Offer - Further accelerated payment terms 13 Mar 2017 4:34PM $3.240 $3.240 $3.240 fallen by 0%
- HCM Offer - Change of substantial holding notice 13 Mar 2017 8:57AM $3.240 $3.240 $3.240 fallen by 0%
- Appendix 3B for Share Rights 13 Mar 2017 8:35AM $3.240 $3.240 $3.240 fallen by 0%
- HCM Offer - Change of substantial holding notice 10 Mar 2017 9:09AM $3.250 $3.240 $3.240 fallen by 0.31%
- HCM Offer declared unconditional 9 Mar 2017 10:09AM $3.240 $3.240 $3.240 fallen by 0%
- HCM Offer - Change of substantial holding notice 9 Mar 2017 9:12AM $3.240 $3.240 $3.240 fallen by 0%
- HCM Offer - CHAMP will Accept the HCM Offer 8 Mar 2017 3:06PM $3.235 $3.240 $3.240 risen by 0.15%
- HCM Offer - Notice of change of interest under IAF 8 Mar 2017 8:54AM $3.230 $3.240 $3.240 risen by 0.31%
- Becoming a substantial holder 8 Mar 2017 8:27AM $3.230 $3.240 $3.240 risen by 0.31%
- HCM Offer update 8 Mar 2017 12:20AM $3.230 $3.240 $3.240 risen by 0.31%
- Potential waiver of 50% minimum acceptance condition 6 Mar 2017 6:04PM $3.210 $3.240 $3.240 risen by 0.93%
- HCM Offer - Minimum Acceptance Reduced to 35% 6 Mar 2017 5:52PM $3.210 $3.240 $3.240 risen by 0.93%
- HCM Offer - Notice of change of interest under IAF 6 Mar 2017 8:55AM $3.210 $3.240 $3.240 risen by 0.93%
- HCM Offer - Further extension of offer period 2 Mar 2017 9:28AM $3.230 $3.240 $3.240 risen by 0.31%
- HCM Offer - Notice of change of interest under IAF 2 Mar 2017 9:01AM $3.230 $3.240 $3.240 risen by 0.31%
- Communication to Shareholders regarding HCM Ltd Takeover Bid 24 Feb 2017 4:27PM $3.250 $3.240 $3.240 fallen by 0.31%
- HCM Offer - Change of substantial holding notice 24 Feb 2017 9:09AM $3.250 $3.240 $3.240 fallen by 0.31%
- HY17 Results Presentation 21 Feb 2017 9:01AM $3.230 $3.240 $3.240 risen by 0.31%
- HY17 Results Media Release 21 Feb 2017 9:00AM $3.230 $3.240 $3.240 risen by 0.31%
- HY17 Appendix 4D and Accounts 21 Feb 2017 9:00AM $3.230 $3.240 $3.240 risen by 0.31%
- HCM Offer - Change of substantial holding notice 21 Feb 2017 8:55AM $3.230 $3.240 $3.240 risen by 0.31%
- HCM Offer - Change of substantial holding notice 20 Feb 2017 8:57AM $3.230 $3.240 $3.240 risen by 0.31%

26 - 50 of 251 results

Page 2 of 11

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.